ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1184

High Mobility Group Box 1 Plays a Role In Gouty Arthritis

Kiwon Moon1, Jinhyun Kim2 and Yun Jong Lee3, 1Internal medicine,, Kangwon National University Hospital, Chuncheon city, Kangwon province, South Korea, 2Internal medicine, Chungnam National University School of Medicine, Daejeon, South Korea, 3Division of Rheumatology, Department of Internal Medicine,Seoul National University Bundang Hospital, Seongnam, South Korea

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

High mobility group box 1 (HMGB1) is a crucial cytokine that mediated the response to infection, injury and inflammation. It is recently discovered that HMGB1 plays a role in the pathogenesis of inflammatory arthritis, such as rheumatoid arthritis. However, the role of HMGB1 in gouty arthritis has not yet determined. The purpose of the study was to investigate the role HMGB1 in gouty arthritis

Methods: HMGB1 concentrations of the synovial fluid (SF) of gouty arthritis and osteoarthritis (OA) were measured by ELISA. Immunohistochemistry was performed in synovial tissue of gouty arthritis and OA. Double immunofluorescence staining was also performed using anti-CD55, anti-CD68, and anti-HMGB1 antibody. In vitro THP-1 cell was stimulated by monosodium urate (MSU) crystal and lipopolysaccharide (LPS). HMGB1 and IL-1β concentrations were measured by ELISA. THP-1 cell and synovial fibroblast were stimulated by IL-1β alone or in complex with HMGB1. IL-1β, IL-6, TNF-α levels were measured by ELISA, and cyclooxygenase-2 (COX-2) expression was assessed by Western blot.

Results:

HMGB1 concentration was significantly higher in SF of gouty arthritis than that of OA (73.1±57.1 vs 14.8±7.3, p < 0.01). Immunohistochemistry revealed that HMGB1 was localized in the nucleus of synoviocyte in OA. However, in gouty arthritis, HMGB1 was found in the cytoplasm of synoviocyte as well as nucleus. Double immunofluorescence staining showed that HMGB1 was found in mainly synovial fibroblast in gouty arthritis. MSU crystal and LPS induced HMGB1 and IL-1β production in THP-1 cell. However, IL-1β, IL-6, TNF-α levels and COX-2 expression were not stimulated by IL-1β alone or IL-1β/HMGB1 complex in THP-1 cell. IL-1β alone enhance COX-2 expression, but IL-1β/HMGB1 complex decreased COX-2 expression in synovial fibroblast.

Conclusion: HMGB1 was highly expressed in SF and synovial tissue in gouty arthritis. MSU crystal and LPS induced HMGB-1 and IL-1β production in macrophage. Extracellular HMGB1 decreased IL-1β induced COX-2 expression in synovial fibroblast. These findings suggest that HMGB1 might plays as an anti-inflammatory mediator in gouty arthritis.


Disclosure:

K. Moon,
None;

J. Kim,
None;

Y. J. Lee,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-mobility-group-box-1-plays-a-role-in-gouty-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology